BTN2A2
BTN2A2 (butyrophilin subfamily 2 member A2, also known as BTF2, BT2.2 and BTN2.2) is a membrane glycoprotein of the immunoglobulin superfamily. It inhibits the proliferation of activated CD4 and CD8 T-cells and restrains T-cell metabolism and cytokine secretion. Browse Assay Genie's current range of BTN2A2 research reagents below, or read on for the biology behind the target.
BTN2A2 inhibits the proliferation of CD4 and CD8 T-cells that have been activated with anti-CD3 antibodies. It also dampens T-cell metabolism and the secretion of IL-2 and IFN-γ. These properties place the BTN2A2 protein among the negative regulators of T-cell activation, and make it a topic of interest in immune regulation studies.
The BTN2A2 gene is a member of the BTN2 subfamily of butyrophilin genes. It lies in a cluster on chromosome 6 of seven genes in the expanding B7/butyrophilin-like group, a subset of the immunoglobulin gene superfamily. The encoded protein is a type I receptor glycoprotein, and UniProt assigns it to the immunoglobulin superfamily and the BTN/MOG family. HGNC classifies it with the butyrophilins, which contain V-set and C2-set immunoglobulin-like domains. Several alternatively spliced transcript variants encoding different isoforms have been reported.
Butyrophilin was first identified as the major protein associated with fat droplets in milk, which explains the family name. NCBI Gene describes the BTN2A2 product as involved in lipid, fatty-acid and sterol metabolism, in addition to its immunological activity. The gene was formerly named butyrophilin, subfamily 2, member A2, and the mouse ortholog is Btn2a2. Related family members include BTN2A1, BTN3A1 and BTN1A1, which are often studied alongside it.
BTN2A2 inhibits proliferation of CD4 and CD8 T-cells activated by anti-CD3, making it a tool for studying negative control of T-cell responses.
The protein suppresses IL-2 and IFN-γ secretion by activated T-cells, relevant to work on cytokine regulation.
BTN2A2 inhibits T-cell metabolism, linking this butyrophilin to research on how metabolic state shapes lymphocyte activation.
NCBI Gene describes the encoded glycoprotein as involved in lipid, fatty-acid and sterol metabolism, supporting studies across the butyrophilin family.
BTN2A2 is a membrane protein that inhibits the proliferation of CD4 and CD8 T-cells activated by anti-CD3 antibodies. It also inhibits T-cell metabolism and the secretion of IL-2 and IFN-γ. NCBI Gene additionally links it to lipid, fatty-acid and sterol metabolism.
BTN2A2 is also known as BTF2, BT2.2 and BTN2.2. Its earlier HGNC name was butyrophilin, subfamily 2, member A2. NCBI Gene reports several alternatively spliced transcript variants that encode different isoforms of the protein.
A mouse ortholog, Btn2a2, is recorded for the human gene. BTN2A2 belongs to the butyrophilin family within the immunoglobulin superfamily and sits in a chromosome 6 cluster of B7/butyrophilin-like genes. Check the datasheet of any product for its validated reactivity.
Other butyrophilin and butyrophilin-like family members involved in immune regulation, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8WVV5; product specifications from Assay Genie datasheets.